Cas12a

Cas12a

Sickle Cell Disease, SCD, (EDIT-301)
Sponsors:
Editas Medicine 
Indicator
IND Enabling
Phase I
Phase II
Phase III
Beta-Thalassemia,
Sponsors:
Editas Medicine
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine